Swissmedic
REGULATORY UPDATE
1 September 2026 – New: FAQ on Swissmedic Fees Ordinance
Published: 9/1/2026Detected: 9/4/2026
Summary preview
FAQ on Swissmedic Fees Ordinance provides interpretive clarification on how Swissmedic fees are assessed and managed under the Fees Ordinance.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#Swissmedic
#fees ordinance
#FAQ
#regulatory fees
#submission process
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
- Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances10/1/2026
- Revision of the Guidance document Authorisation Biosimilar10/1/2026
- Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
- I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026